PTSD :: Grief & trauma in the aftermath of Virginia Tech Shootings
Experts in grieving and post-traumatic stress disorder are available as sources for media covering the aftermath of the tragic shootings at Virginia Tech.
Professor
Ovarian Cancer :: HRT increases ovarian cancer risk
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
Cancer :: Nanotechnology revolutionising cancer diagnostic testing
University of Queensland researchers are using nanotechnology to revolutionise medical diagnostic testing of diseases such as cervical cancer.
Brain Cancer :: Search-and-destroy therapy for human brain cancer
Researchers in Germany have hidden vaccine-grade measles virus inside artificially generated blood cells in order to devise a search-and-destroy therapy for human brain cancer that can?t be “seen” by the immune system.
Prostate Cancer :: Eradication of resistant prostate cancer by a novel gene therapy
A research team at Columbia University has designed a novel viral-based gene therapy they say blasts through a body, targeting both primary and distant tumors, while leaving normal cells untouched.
Colorectal Cancer :: KRAS mutation in colorectal cancer patients treated with Cetuximab
Mutations in the KRAS oncogene could predict a lack of response to the drug cetuximab in patients with colorectal tumors. For those with the mutations, the drug is likely to be inefficient and possibly harmful, according to researchers at France?s Institut National de la Sante et de la Recherche Medicale (INSERM).
Head and Neck Cancer :: Vaccination for squamous cell carcinoma of the head and neck
Researchers from the University of Pittsburgh and the Gunma University School of Medicine have developed a vaccine that enlists multiple parts of the immune system into targeting p53 in head and neck squamous cell cancer.
HPV :: Impact on precancerous lesions & HPV infections in women vaccinated with HPV vaccine
Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville.
Breast Cancer :: Breast cancer incidence continues to trend low in 2004, decline supports role of HRT
An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy and increased breast cancer incidence, according to research led by scientists at the University of Texas M. D. Anderson Cancer Center and published in the April 19 issue of the New England Journal of Medicine.
Addiction :: UCSF launches study on treatment for prescription drug addiction
UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.